Cue Biopharma Inc

NASDAQ:CUE   12:10:27 PM EDT
3.08
-0.08 (-2.53%)
Earnings Announcements

Cue Biopharma Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 21:33 GMT
Cue Biopharma Inc (CUE) - Cue Biopharma Reports Second Quarter 2022 Financial Results.
Cue Biopharma Inc - Qtrly Net Loss per Common Share - Basic and Diluted $0.37.
Revenue is expected to be $1.13 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $5.66 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.